Physician profile
Stephen Smith
NPI 1124050851
$30,988.94
in general payments reported to CMS, 2019-2025
20 companies · $19K in 2025
The $19K reported for 2025 was more than what 89% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,632 · 2020: $1,186 · 2021: $993 · 2022: $1,782 · 2023: $2,147 · 2024: $3,488 · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $14K · Food and Beverage: $9,954 · Travel and Lodging: $319 · Education: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $14,007.88 |
| Food and Beverage | $9,954.31 |
| Travel and Lodging | $319.42 |
| Education | $114.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Happe Spine | $14,441.35 | 2024-2025 | Integrate-C |
| Medtronic, INC. | $11,839.17 | 2021-2025 | Unid_pass, Catalyft Pl Expandable Interbody System, Kyphon Express II Kyphopak Tray |
| Medtronic USA, INC. | $3,458.20 | 2019-2020 | |
| Stryker Corporation | $276.70 | 2019 | |
| Arteriocyte Medical Systems, INC. | $147.36 | 2024 | Magellan |
| Icotec Medical INC. | $146.63 | 2025 | Kong-Tl Vbr E, Expandable Body, L, 19 Mm X 27 - 37 Mm, Kong-Tl Vbr, End Plate, Round, L and Screw, 12 X 43 Mm, Vader Pedicle System, Rod, Carbon/Peek, Curved, 6.0 R450 X 200 Mm |
| Astellas Pharma US INC | $135.07 | 2023-2024 | Veozah |
| Orthopediatrics Corp. | $125.29 | 2023 | |
| Biocomposites INC | $121.71 | 2025 | Stimulan |
| Globus Medical, INC. | $68.17 | 2022-2024 | Excelsius3d Imaging System |
| Medicrea USA, Corp. | $40.24 | 2019 | |
| Orthofix Medical, INC. | $32.03 | 2021 | |
| Si-Bone, INC. | $27.84 | 2022-2024 | |
| Sunovion Pharmaceuticals INC. | $25.61 | 2019 | |
| Abbvie INC. | $20.73 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $20.00 | 2024 | Kcentra |
| Providence Medical Technology, INC. | $19.29 | 2023 | |
| Zimmer Biomet Holdings, INC. | $16.90 | 2019 | |
| Sanara Medtech INC. | $13.59 | 2022 | |
| Integra Lifesciences Corporation | $13.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$4,428,303.14 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.